Name Human Gene Therapy

View Statistics Email Alert RSS Feed

Title Issue Date
Preliminary safety and efficacy of DB-OTO gene therapy in pediatric patients with profound deafness due to otoferlin variants: The CHORD phase 1/2 open-label trial Bance, M.; Lustig, L.; Ishiyama, A.; Nash, R.; Polo, R., et al Issued date: 2025 Source: Human Gene Therapy [ISSN 1043-0342],v. 36 (3-4), p. E136, Abstract OR016, (Febrero 2025) SJR: 1,137 - Q2 JCR: 4,0 - Q1 SCIE MIAR ICDS: 11,0 Actas de congresos

Bance, M.; Lustig, L.; Ishiyama, A.; Nash, R.; Polo, R., et al

Issued date: 2025

Source: Human Gene Therapy [ISSN 1043-0342],v. 36 (3-4), p. E136, Abstract OR016, (Febrero 2025)

SJR: 1,137

- Q2

JCR: 4,0

- Q1

SCIE

MIAR ICDS: 11,0

Actas de congresos